Proprietary, game-changing technology.

Andres Betts PhD,is the mastermind and driving force behind Canal 33’s superior platform and team.

The flagship of Canal 33’s product line, the Betts RF Catheter radically reduces the cost of RF treatment for patients while making the procedure more simple and effective for physicians administering spinal cord stimulation to patients around the United States today.

People deserve to live a life without pain.

Low-back pain is the single leading cause of disability worldwide. Millions around the world go through years of discomfort and in some cases, chronic agonizing pain.

Our passion is to develop sustainable and efficient technologies that can get into the hands of pain specialists and as a result, change lives. We’re passionate about developing medical devices that impact both the medical community and the world as a whole.

Precision. Accuracy. Relief.

These are the driving principles behind everything we do as physicians, entrepreneurs and members of the medical community. Our team is a mix of talented individuals who think outside the box and have a passion for delivering the best solutions to pain specialists around the world.

Andreas Betts – M.D., Director and Chief Technology Officer

Dr. Betts brings approximately two decades of experience as a physician and interventional pain specialist. An expert in interventional pain and spinal compression fractures, Dr. Betts is a nationally recognized speaker and publisher of multiple articles in peer reviewed medical journals. In addition, he is frequently selected as an instructor for other physicians to learn the specialized techniques of Kyphoplasty and Vertebroplasty, including the instruction of Physician Fellows in University Pain Fellowship programs. Dr. Betts also acts as a consultant for several medical device corporations in new product design, development, and physician support/instruction (names of corporations available on request).

Dr. Betts is licensed in California (#G055823) and Washington state (27397) and holds licensure/certification from: The American Board of Anesthesiology (April 1990). The American Board of Pain Medicine (February 2000), and The National Board of Medical Examiners. Dr. Betts has received graduate training in Critical Care Medicine at the Veterans Administration Medical Center in Long Beach, CA; Obstetric Anesthesia at the University of California at Irvine Medical Center/Women’s Hospital, Long Beach Memorial; Residency in Anesthesiology at the University of California at Irvine Medical Center (December 1985-November 1988); and an Internship in General Surgery from the University of California, San Diego Medical Center (July 1984-June 1985). Dr. Betts received a Doctorate in Medicine from the University of California, San Francisco, School of Medicine (June 1984), and a Bachelor of Arts Degree in Biology from the University of California, San Diego (June 1979).

Douglas Bennett – Director

Mr. Bennett is a member of the Board of Directors. He has had a varied business career working for Fortune 100 firms, both small and medium-sized companies, and being involved with several start-ups. He actively served as a Navy Corpsman with the U.S. Marine Corps from 1961-1963, and served in the Reserves until honorably discharged in 1967. After receiving his B.S. Finance (1966) and his M.B.A. (1967) from the University of Arizona, he embarked on his business career with Shell Oil Co. (1967-1970) and Shell Chemical Co. (1970-1973), progressing through increasingly responsible supervisory and management positions in finance, credit, auditing and accounting. His final three years were spent dealing with mergers and acquisitions. In 1973 he was recruited as the Vice President of Phydeaux Corporation, a financial services and investment firm that served medical professionals’ financial needs. In 1973 he co- founded and was President (1973-1974) of the California Energy Company, a geothermal power generation firm subsequently sold to Berkshire Hathaway.

From 1974 through 1992, Mr. Bennett became a full time entrepreneur and formed Doug Bennett Enterprises, Inc., a holding company for investments in and management of major brand service stations and automotive service firms (including Shell, Texaco, Unocal and Big O Tires). Doug Bennett Enterprises and Mr. Bennett later became General partner of Calzona Partners (1985- 1991), an Arizona real estate developer that focused on the purchase and development of distressed properties for subsequent sale to private investors and merchant builders such as Pulte Corp. As President of Doug Bennett Enterprises he invested in commercial real estate, golf course development, and activities in transportation (Shuttle Express, where he was a Board Member) during the period of 1993-1999. In 2000, Mr. Bennett invested in and later took control of a struggling home décor company called Forever Green Art, Inc. (FGA). as President and Chairman (2000-2003). FBA was returned to profitability and was sold through a management buy-out in 2003. Since 2003, to date, Mr. Bennett has continued his business career as a private investor and volunteers his time to civic, charity and church endeavors.

Latest News

March 5, 2019 in Business

Canal 33 Announces the Issuance of Key US Patent for Expandable Blade Device for Stabilizing Long Bone Fractures 

S AN CLAMENTE, Calif. – May xx, 2016 – Canal 33, an innovative medical device company addressing chronic spinal pain conditions through the development of leading-edge technologies, announces the issuance... Read More
February 24, 2019 in Business

Canal 33 Announces Issuance of Two Key US Patents for the Protection of Proprietary Radio Frequency Catheters

S AN CLAMENTE, Calif. – May 23, 2016 – Canal 33, an innovative medical device company addressing chronic spinal pain conditions through the development of leading-edge technologies, announces the issuance... Read More
January 10, 2019 in Business

Canal 33 Announces the Issuance of Key US Patent for Expandable Blade Device for Stabilizing Compression Fractures 

S AN CLEMENTE, Calif. – May 23, 2016 – Canal 33, an innovative medical device company addressing chronic spinal pain conditions through the development of leading-edge technologies, announces the issuance... Read More